Covered recipient · General Payments record
GIOVANNI CASTELLUCCI
General Payments · PY2023–2024
$614.27
- Reported across 17 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $458.61 | 12 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Neurelis, Inc. | $189.95 | 5 |
| JAZZ PHARMACEUTICALS INC. | $121.83 | 1 |
| LivaNova USA, Inc. | $51.77 | 2 |
| GENZYME CORPORATION | $35.67 | 1 |
| ACADIA Pharmaceuticals Inc | $24.49 | 1 |
| SK Life Science, Inc. | $20.99 | 1 |
| Biogen, Inc. | $13.91 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (12)
Sorted by paying entity, then date · as published by CMS
Program year 2024 2023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ACADIA Pharmaceuticals Inc | $24.49 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147965850 | CMS |
| Biogen, Inc. | $13.91 | 07/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104834085 | CMS |
| GENZYME CORPORATION | $35.67 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139626026 | CMS |
| JAZZ PHARMACEUTICALS INC. | $121.83 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150208230 | CMS |
| LivaNova USA, Inc. | $28.10 | 01/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152798001 | CMS |
| LivaNova USA, Inc. | $23.67 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152798099 | CMS |
| Neurelis, Inc. | $1.67 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145636871 | CMS |
| Neurelis, Inc. | $20.05 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145636876 | CMS |
| Neurelis, Inc. | $28.47 | 10/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145636880 | CMS |
| Neurelis, Inc. | $28.45 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145636889 | CMS |
| Neurelis, Inc. | $111.31 | 12/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145636894 | CMS |
| SK Life Science, Inc. | $20.99 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154149971 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2023, 2024
- Source files
- Dataset page · Bulk file · PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.